Outstanding Manuscript Research Articles

Outstanding Manuscript Awards

Congratulations to the winners of the 2013 Outstanding Manuscript Awards, as determined by the Editorial Board and the Editors of the Journal of Athletic Training:

Editorial: 2013—A Year of Clinical Success and Great Scientific Innovation in the Stem Cell Field

The year 2013 has been an extremely excitingone for the field of stem cell research andtherapy. Our “sister journals,” STEM CELLS andSTEM CELLS TRANSLATIONAL MEDICINE, havedone a great job of capturing the excitingadvances in the field, thanks to the outstand-ing manuscripts submitted by our authors.STEM CELLS manuscripts focus primarily onthe functional and mechanistic aspects of stemcell biology and the potential of different typesof stem cells for therapeutic applications, andreports key advances in stem cell clinical trials.Manuscripts must have definitive conclusionsto be considered for potential publication inSTEM CELLS. The manuscripts in STEM CELLSTRANSLATIONAL MEDICINE (SCTM) primarilycover technical advances in delivering cell ther-apy, advances in animal models, and new find-ings that help advance particular stem celltherapies closer to the clinic. SCTM providesan excellent forum for translational, clinical,and technical advances for stem cell therapydevelopment. After only 1 year in press, wewere thrilled to announce that SCTM becamefully indexed in PubMed. This is a wonderfultestimony to the huge amount of excitementin the field and to the truly excellent manu-scripts submitted to both sister journals.During the past year, STEM CELLS has beenproud to publish exciting clinical advances intreating steroid-refractory Graft versus Hostdisease [1], Cerebral Palsy [2], Crohn’s fistula[3], and treating alveolar bone defects with aninjectable tissue engineered stem cell product,avoiding the donor site morbidity associatedwith bone autograft [4].We were also excited to publish an excel-lent review on the current clinical status ofmesenchymal stem/stromal cell (MSC) thera-pies for inflammatory diseases [5], a review ofengineering myocardial tissue [6], and concisereviews on clinical programs of stem celltherapies for liver and pancreas [7], stem cellsfor treating lung disease [8], MSCs for ischemickidney disease [9], and salivary gland stemcells for treating xerostomia/hyposalivation[10].These clinical reports and reviews of com-pleted and ongoing stem cell clinical trialswere accompanied by a dazzling assortment ofbasic and translational research toward betterunderstanding and treating a plethora of dis-eases and injuries. Manuscripts covered manyadvances in understanding the fundamentalmechanisms that control stem and progenitorcell fate, and advances in working towardtreating all tissues, from the lower extremitiesto the brain. Exciting basic and translationalresearch was reported in using stem cells totreat osteoporosis [11], spinal cord injuries[12, 13], radiation-induced fibrosis [14], glau-coma [15], globoid cell leukodystrophy [16],stroke [17], and Huntington’s disease [18], toname just a few. It has truly been an excitingyear, as we watch the stem cell field explode.In order to help readers keep up with theirareas of interest, STEM CELLS provides virtualissues in specific areas, which are collectionsof the most exciting papers over the past 2years in a given field. These can be accessedon the STEM CELLS website. Some of the mostrecent collections are: “Neural Stem CellsPapers,” “Induced Pluripotency—Making StemCells for All Reasons,” and “MSCs for WhatAils You.”The STEM CELLS Portal provides updateson exciting news in the field and links toadvances that are reported in both sister jour-nals. There is a link on the portal to an audiosection called “Innovators and Issues,” whichconnects listeners with leaders in the field ofstem cell research and translational medicine.The website also has a link to the younginvestigator awards. Dr. Jacco van Rheenen’smanuscript, “Intravital Imaging of Cancer StemCell Plasticity in Mammary Tumors,” publishedin the March 2013 issue of the Journal, wasselected as the

Setting standards for medical writing in orthopaedics

Once the privilege of few clinical scholars in the field of orthopaedics, medical writing has become a must for career advancement. The number of papers submitted and published yearly has increased steadily, and with the development of the Internet, manuscript and journals have become easily accessible. Medical writing has risen to become a discipline in itself, with rules and standards. However, heterogeneity in the quality of papers submitted still prevails, with large variations in both form and content. With countries such as China and India submitting an exponential number of manuscripts, it is important and helpful that standards of medical writing be emphasised to help writers who do not always have the required support to produce an outstanding manuscript. In this paper, we summarise what may become standards for medical writing in the field of orthopaedics.

PCDRecognizes Outstanding Student Research: Patel et al on Emergency Medical Services Capacity for Prehospital Stroke Care in North Carolina

This week, Preventing Chronic Disease (PCD) publishes the winning submission in the journal’s third annual Student Research Paper Contest, “Emergency Medical Services Capacity for Prehospital Stroke Care in North Carolina,” by Mehul D. Patel and colleagues (1). The contest is part of PCD’s effort to support and encourage the development of the next generation of public health professionals. Mr Patel is an epidemiology student in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, and Dr Wayne Rosamond is his academic and dissertation advisor. As in previous years, submissions in the 2013 contest examined a range of topics and used a variety of analytic methods. Since the first contest in 2011, the quality of the submissions has improved, making the final decision that much more difficult for the panel of judges. As Patel and colleagues note, stroke morbidity and mortality is high in the United States and in North Carolina. It is well known that early treatment of stroke can make a difference in event outcomes. During the past decade, efforts have been made to raise public awareness of stroke signs and symptoms and the importance of acting early and to increase the knowledge and capacity of emergency medical services (EMS) to improve health outcomes. Patel and colleagues examined improvements in EMS capacity to identify and treat stroke in North Carolina from 2001 through 2012. A statewide survey in 2001 found deficiencies in EMS education and the use of protocols. The authors’ survey in 2012 documented major improvements since 2001, especially in prehospital stroke screening, and highlighted other areas that remain in need of improvement, including the use of destination plans. This article nicely demonstrates the relationship among data, health, health care, and policy. The 2001 survey documented the need to improve the stroke care capacity of EMS systems in North Carolina, and surveillance data documented the burden of stroke (2,3). Together, this information supported the development and passage of state legislation in 2006 to address the availability of stroke-related resources among hospitals and EMS systems and the implementation of standardized EMS stroke care practices and policies. Results from the 2012 survey indicated that EMS had made progress in its capacity to provide services. The decline in stroke mortality in North Carolina documented by external data sources provides some ecological support to changes in health outcomes. The study had one limitation that highlights an opportunity for collaboration between clinical and public health systems: the study had no direct measures of services provided, patient outcomes, or population-level indicators. This limitation points to a challenge faced by many public health researchers: access to health outcome data in addition to process and proxy outcome measures. Direct measurement of health outcomes is ultimately needed to determine intervention effectiveness and to make a convincing argument for public health programs and policies. In North Carolina, the decline in stroke mortality documented by external data sources parallels changes in policy and service protocols. However, Patel’s study did not include data on health outcomes or services provided, both of which could offer evidence that changes in health outcomes resulted from changes in policies and service protocols. Data from other sources can sometimes be used to triangulate findings; however, this approach has limitations. This gap in data highlights an opportunity for clinical and public health systems to work together to collect data that will provide the strongest evidence to evaluate policy changes. Congratulations to Mr Patel and his colleagues on their outstanding work. We invite you to read the winning article (www.cdc.gov/pcd/issues/2013/13_0035.htm) and to listen to the accompanying podcast, an interview with the author. The study represents exceptional work, selected from a pool of several outstanding manuscripts, performed by members of the next generation of public health researchers. Although there can be only one contest winner, we were pleased to find that several manuscripts were of sufficient merit to warrant future publication in PCD. The review process for these student submissions was conducted by a panel of PCD editorial board members as well as Ellen Kersten, winner of the 2012 PCD Student Research Paper Contest. We look forward to the next round of student papers for the 2014 contest. The deadline for submission of student papers is January 31, 2014.

2012JOSPTAward Recipients Highlight Early Injury Detection

During the American Physical Therapy Association's Combined Sections Meeting in San Diego in January 2013, JOSPT recognized the authors of the most outstanding research and clinical practice manuscripts published in JOSPT during the 2012 calendar year. The 2012 JOSPT Excellence in Research Award was presented to Ivan Mulligan, Mark Boland, and Justin Payette for their paper titled “Prevalence of Neurocognitive and Balance Deficits in Collegiate Football Players Without Clinically Diagnosed Concussion.” The 2012 George J. Davies-James A. Gould Excellence in Clinical Inquiry Award was presented to Richard B. Souza, Thomas Baum, Samuel Wu, Brian T. Feeley, Nancy Kadel, Xiaojuan Li, Thomas M. Link, and Sharmila Majumdar for their work titled “Effects of Unloading on Knee Articular Cartilage T1rho and T2 Magnetic Resonance Imaging Relaxation Times: A Case Series.” J Orthop Sports Phys Ther 2013;43(3):115–116. doi: 10.2519/jospt.2013.0102

Goodbye International Journal of Andrology, welcome Andrology!

Goodbye <i>International Journal of Andrology</i>, welcome <i>Andrology</i>!

Kudos to our outstanding manuscript reviewers

Kudos to our outstanding manuscript reviewers

Staff Letter

Dear Authors,We are so grateful to each of you for continuing to provide Operative Dentistry with such outstanding manuscripts to consider. We have seen a steady increase each year in the number of manuscripts that are sent to us for publication consideration. For example 20 years ago, during the 1992 volume year, we received 68 manuscripts for consideration, and printed 33 an acceptance rate of 48%; 10 years ago, during the 2002 volume year, we received 212 manuscripts—a 311% increase, 93 were printed putting our acceptance rate at 43%; last year we received 505—a 238% increase over 2002 and a 742% increase over 1992, 80 were printed (more pages than in 2002) for a 15% acceptance rate. As you can see, we are having to become more and more selective in the articles we publish, not only that, but because of the costs of maintaining a manuscript submission system that can deal with this kind of traffic, our costs are exponentially increasing as well. Unfortunately, it has come time that we need to pass a small portion of these costs on to our submitting authors. Operative Dentistry is charged by our submission vendor 25.00USD per manuscript that goes through our system, whether it is accepted for publication or not. Beginning with the first submission of 2013, that cost will now be charged to our authors to submit a manuscript into our system. This 25.00USD fee will be required for a manuscript to be considered in any way. Please understand that this fee is charged to us by our vendor, and will be non-refundable. Paying the submission fee will have no bearing on whether or not your manuscript will be accepted either for review, or for publication. We thank you for understanding the necessity of this step. Should you have any questions about this new policy, please contact our offices at editor@jopdent.org.Sincerely,Operative Dentistry Office Staff

2011 outstanding manuscript awards

2011 outstanding manuscript awards

PG 8.01 Writing and submitting an outstanding scientific manuscript

PG 8.01 Writing and submitting an outstanding scientific manuscript

Editorial

Editorial

Kudos to Our Outstanding Manuscript Reviewers

Kudos to Our Outstanding Manuscript Reviewers

Top Advances in Functional Genomics and Translational Biology for 2010

In recent years, major advances have been made in transcriptomics, metabolomics, proteomics, and particularly population genetics. More than 850 genome-wide association studies (GWAS) were published by the end of 2010, now covering a vast number of diseases and phenotypes and often incorporating tens of thousands of subjects or, in some cases, more than 100 000 subjects, increasing statistical power to identify and replicate contributing loci. Sequencing throughput advances and decreasing costs per sample have allowed the application of genome-wide genotyping and sequencing technology to larger DNA samples as well as transcriptome and epigenome features. This year was marked not only by continuing progress with GWAS, sequencing, and copy number variation studies but also by follow-up of GWAS and other findings with functional studies that uncover new molecular pathways contributing to disease and pave the way for future clinical applications. The American Heart Association Functional Genomics and Translational Biology Interdisciplinary Council (http://www.americanheart.org/presenter.jhtml?identifier=3016539) provides a forum for a multidisciplinary group of volunteers committed to making a substantial contribution to reduce the burden of heart disease and stroke through genetics, genomics, proteomics, and metabolomics research and translational science. With input from the Early Career Committee of the Council on Functional Genomics and Translational Biology, we considered many papers and selected 10 outstanding manuscript groups (15 articles) published in 2010 that reflect these advances, and we briefly summarize each below in chronological order.

Commentaries--another addition to the portfolio of Circulation Research.

HomeCirculation ResearchVol. 108, No. 2Commentaries—Another Addition to the Portfolio of Circulation Research Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBCommentaries—Another Addition to the Portfolio of Circulation Research Roberto Bolli, Aruni Bhatnagar, A. J. Marian and the Editors Roberto BolliRoberto Bolli Search for more papers by this author , Aruni BhatnagarAruni Bhatnagar Search for more papers by this author , A. J. MarianA. J. Marian Search for more papers by this author and the Editors Search for more papers by this author Originally published21 Jan 2011https://doi.org/10.1161/RES.0b013e31820d7d83Circulation Research. 2011;108:157The ever-increasing number of publications poses a formidable challenge for many investigators: how can one keep up with the advances in science? Inherent in the accelerating pace of discoveries and in the expanding number of platforms for their dissemination is the danger that major scientific leaps may be overlooked or not placed in proper perspective by some segments of the community of scholars. The issue here is not just to be aware of new publications, but also to be able to form a critical opinion regarding their limitations, context, significance, and impact. It is practically impossible to read all new important articles that appear every week, let alone assess their significance.Recognizing this conundrum, the editors of Circulation Research work hard to provide to the readers not only the best possible selection of original articles, but also a broad vista of the most significant advances in cardiovascular biology, regardless of where they are published. It is this philosophy that has motivated us to expand the number of review articles and to introduce new features such as News and Views, Profiles in Cardiovascular Science, Translational Success Stories, Emerging Science, and Controversies in Cardiovascular Research. We also commission Editorials, written by leading experts, to highlight work published in our journal that we feel is particularly noteworthy and merits further discussion.Yet, we realize that we only publish a fraction of the many outstanding manuscripts that appear in the literature. To highlight some of the most important discoveries that are published elsewhere, the Editors have decided to launch a new article category, Commentaries. To this end, the Editors will select articles published in other journals (not necessarily restricted to cardiovascular sciences) that are of particular significance to the cardiovascular scientist and will invite world-class authorities to comment briefly on them. This section will be edited by Aruni Bhatnagar and Ali J. Marian.Each Commentary will be a short, one-page article (maximum of 750 words) in which the authors will describe succinctly their interpretation of the data and their opinion regarding the soundness, impact, significance, and implications of the findings reported in the covered articles. Authors will be encouraged to present their personal interpretation of the data and to address the novelty of the discoveries, the strengths/weaknesses of the methodology, the significance for the broader community of cardiovascular scientists, the potential clinical or translational implications, and directions/areas that need to be addressed in future studies. Commentaries will differ from Editorials in that the latter are restricted to articles published in Circulation Research. Commentaries also differ from News and Views in that the latter are prepared by a professional writer and seek to provide a broad overview of the study and some comments from experts in the field rather than an in-depth cardiovascular perspective of the study written by a scientist working in that field.We are pleased to inaugurate this new feature in the current issue with the Commentary by Alan Tall, titled “Sorting Out Sortilin.” We welcome suggestions from the Editorial Board members and the readers for articles for possible future Commentaries.We hope that Commentaries will not only augment the scientific breadth of the journal but also help our readers keep abreast of major discoveries and of their significance to their own work. Our goal is to offer you a less parochial and more global perspective on cardiovascular science. As always, your comments and suggestions will be greatly appreciated.FootnotesThe opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association. Previous Back to top Next FiguresReferencesRelatedDetailsCited ByBolli R (2019) Ten Years at the Helm of Circulation Research, Circulation Research, 124:12, (1707-1717), Online publication date: 7-Jun-2019. Kolar C, Harrell T and Janke K (2016) Would you care to commentary on that?, Currents in Pharmacy Teaching and Learning, 10.1016/j.cptl.2016.02.022, 8:3, (267-268), Online publication date: 1-May-2016. January 21, 2011Vol 108, Issue 2 Advertisement Article InformationMetrics © 2011 American Heart Association, Inc.https://doi.org/10.1161/RES.0b013e31820d7d83PMID: 21252147 Originally publishedJanuary 21, 2011 PDF download Advertisement

Highlights of the ISOLS/MSTS 2009 Meeting: Editorial Comment

Despite much progress in the last three decades, our patients with musculoskeletal neoplasms deserve better outcomes and quality of life from limb salvage procedures than we currently provide. To accomplish this, we in the profession must direct our attention to more research, more education, and more innovation to minimize disease and preserve patient function. While there are many obstacles to understanding and treating musculoskeletal neoplastic disease, the international community has shown its ability to leverage intellectual and societal resources to make progress. An outstanding example of this was the first combined meeting of the International Society of Limb Salvage (ISOLS) and the Musculoskeletal Tumor Society (MSTS) held in Boston in September 2009. Such collaborative efforts allow orthopaedic surgeons and scientific investigators to document the progress in orthopaedic oncology, highlight the remaining problems with limb salvage, and fertilize clinical and basic research efforts worldwide. The combined MSTS/ISOLS meeting was the largest gathering of orthopaedic oncologists in the world, allowing the most experienced surgeons and scientists to share their research and surgical innovations. Documentation of these proceedings is an essential part of the educational process and provides a foundation for further advances. Both ISOLS and MSTS are grateful to Clinical Orthopaedics and Related Research for this opportunity to share outstanding manuscripts from the meeting and summarize the current state of the art and define the research needs. Limb salvage is a well-accepted approach to the treatment of musculoskeletal sarcoma. Challenges remain, however, in both effective eradication of the local tumor and durability and functional outcome of reconstructive techniques. Several manuscripts in the symposium focus on the adequacy of the surgical resection and surgical margins in relationship to the risk of local tumor recurrence. Local tumor control remains essential for patient survival, yet despite the use of adjuvant therapies such as radiation and chemotherapy, the exact surgical margin necessary to avoid local recurrence remains a critical and poorly defined factor for recurrence. Although dramatic improvements in survival statistics have been realized, especially in pediatric sarcomas, the importance of surgical treatment is emphasized by the lack of recent progress in the development of newer chemotherapeutic agents for adults and children. While we look forward to the development of biologically based cures for sarcoma, the reality is that surgical treatment will remain an essential component of treatment in the foreseeable future. Reconstruction after tumor resection remains demanding, particularly for long-term outcomes. The experiences at several institutions with differing reconstructive techniques are detailed in several papers. It is clear that more durable implants and fixation methods are needed for patients as well as other innovations to decrease the risk of infection and soft tissue complications to improve outcomes. Pediatric patients deserve particular attention and care. The experience of several authors with innovative techniques for limb salvage in the growing child such as physeal preserving resections and use of expandable implants are included. Further study of the longevity and outcomes of these techniques, and others, are needed as many children survive their sarcoma to become patients with challenging reconstructive failures. The papers presented in this symposium reflect the continued efforts of members of both ISOLS and MSTS to advance the science and treatment of patients with musculoskeletal neoplasm. While progress is occurring on many levels, much work still needs to be done. We appreciate the opportunity to edit these outstanding manuscripts. Fig. 1 John H. Healey, MD is shown. Fig. 2 Mary I. O’Connor, MD is shown. Fig. 3 Mark C. Gebhardt, MD is shown.

A New Editor-in-Chief at the Helm!

If asked to list three events that happened in 1941, depending on your age (and memory), you might come up with perhaps one, or draw a total blank. Let me help by informing you first that the Yankees took the World Series (again!) from the Brooklyn Dodgers 4 to 1. More significantly, President Franklin Roosevelt declared war on Japan on December 8, 1941, a day after the bombing of Pearl Harbor. Germany in turn declared war on the United States on December 11, 1941, adding to how momentous a year that was for Americans. Very serious times without question, but there is a brighter side to 1941 insofar as endocrinologists and The Endocrine Society are concerned. The first issue of what was originally the Journal of Clinical Endocrinology (or JCE) appeared in January 1941 as the second journal of our Society, then known as the Association for the Study of Internal Secretions. For you endocrinologists who lament that the public has little idea what an endocrinologist is or does, consider that it could be much worse if you still were described as a specialist in internal secretions! The JCE started as a monthly publication at a cost of $6.50 per year, the price of a single movie ticket today (at least for senior citizens). Our Society’s first journal was Endocrinology, initially appearing in January 1917, and it was the growing submission of clinical papers to the latter that led to the birth of the JCE. As far as I can tell, there was no single Editor-in-Chief (EIC) of the JCE, but rather a starstudded “Editorial Committee” that included the famous Dr. Fuller Albright. Articles in that first issue included one by George Thorn on the use of steroids for adrenal insufficiency and one by Lawson Wilkins on treatment with desiccated thyroid of hypothyroidism in children. January 1952 saw the “M” added to the JCE and publication of the first issue as the Journal of Clinical Endocrinology & Metabolism. January 2010 now marks another milestone for the Society and the JCEM. After 5 outstanding years as EIC, Dr. Paul Ladenson has stepped down. These past 5 years have seen remarkable enhancements in the Journal that have led to both its greater popularity with the readership and tangible evidence of its importance in the field. That importance was demonstrated again this past year by a significant rise in the Journal’s “impact factor,” which is a measure of the frequency of citation of JCEM articles. Dr. Ladenson’s achievements were facilitated, nourished, and enhanced by an exceptional group of Associate Editors, Editorial Board members, and reviewers. On behalf of the Journal and the Society, I thank the departing Editors and Editorial Board members for their dedication. The quality and hard work of this team notwithstanding, the Journal would not have achieved its success by their efforts alone. Importantly, it has been the submission of outstanding manuscripts from clinical investigators and clinicians like you that has shaped the Journal into a repository of the best in endocrine scientific inquiry and commentary. Indeed, our authors have heeded Benjamin Franklin’s admonition in Poor Richard’s Almanac:

2008 Outstanding manuscript awards

2008 Outstanding manuscript awards

In Memoriam: David J. Macey

In Memoriam: David J. Macey

JOSPTAuthors Honored at CSM 2008

During APTA's Combined Sections Meeting in Nashville last month, the Journal of Orthopaedic & Sports Physical Therapy recognized for the fourth time the most outstanding research manuscript and clinical practice paper published in the JOSPT within a calendar year. The JOSPT Excellence in Research Award is given to the best article published within the category of research reports. The George J. Davies-James A. Gould Excellence in Clinical Inquiry Award is presented to the best article among the categories of case reports, resident's case problems, clinical commentaries, and literature reviews. An award committee consisting of the JOSPT editor-in-chief, 2 JOSPT associate editors, and the research chairs of the Orthopaedic and Sports Physical Therapy Sections selected the recipients. J Orthop Sports Phys Ther 2008;38(3):99–100. doi:10.2519/jospt.2008.0104

JOSPTAwards Debut at CSM 2005

During APTA's Combined Sections Meeting in New Orleans last month, the Journal of Orthopaedic & Sports Physical Therapy recognized for the first time the most outstanding research manuscript and clinical practice paper published in JOSPT within a calendar year. Presentations of the awards were made at the awards receptions of the Orthopaedic and Sports Physical Therapy Sections. J Orthop Sports Phys Ther 2005;35(3):128–129. doi:10.2519/jospt.2005.0103